Published in Lab Business Week, July 3rd, 2005
The company's stock will continue to be listed on The Nasdaq SmallCap Market until the hearing has been held and the panel has issued a decision. A hearing date has not yet been set, but Nasdaq rules require that the hearing be held within the next 45 days.
As previously reported on a Form 8-K filed with the Securities and Exchange Commission on April 25, 2005, the company received a letter...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.